ARCHIVES

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

Development Of New Screening System For Antimetastasis Drugs Approved

June 25, 1982

NCI Plans To Recomplete CCOP; Future Direction To Be Discuss At DCPC Board, NCAB Meetings

January 17, 1986

NCI Communications Office to contract Media Campaigns

October 22, 1993

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

June 5, 2009

SSO Workshop Calls For Certification of Surgical Oncologists, Increased Commitments By NCI, ACS

November 18, 1983

NCI National Lab’s Budget to Grow Over Its $299.2 Million FY2013 Level

February 28, 2014